Cargando…
Recent progress of antiviral therapy for coronavirus disease 2019
The coronavirus disease 2019 (COVID-19) pandemic has become a global public health crisis, for which antiviral treatments are considered mainstream therapeutic approaches. With the development of this pandemic, the number of clinical studies on antiviral therapy, including remdesivir, chloroquine an...
Autores principales: | Zhao, Mengmeng, Zhang, Jishou, Li, Hanli, Luo, Zhen, Ye, Jing, Xu, Yao, Wang, Zhen, Ye, Di, Liu, Jianfang, Li, Dan, Wang, Menglong, Wan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584884/ https://www.ncbi.nlm.nih.gov/pubmed/33190802 http://dx.doi.org/10.1016/j.ejphar.2020.173646 |
Ejemplares similares
-
Advances in the relationship between coronavirus infection and cardiovascular diseases
por: Zhao, Mengmeng, et al.
Publicado: (2020) -
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages
por: Zhao, Mengmeng, et al.
Publicado: (2020) -
The Association between Obesity and Severity in Patients with Coronavirus Disease 2019: a Retrospective, Single-center Study, Wuhan
por: Zhang, Jishou, et al.
Publicado: (2021) -
Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
por: Wang, Menglong, et al.
Publicado: (2022) -
The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
por: Zhang, Jishou, et al.
Publicado: (2020)